- Investing.com
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. Its product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Metrics to compare | LFCR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLFCRPeersSector | |
---|---|---|---|---|
P/E Ratio | −6.4x | −2.4x | −0.5x | |
PEG Ratio | 0.01 | −0.10 | 0.00 | |
Price/Book | 213.1x | 1.8x | 2.6x | |
Price / LTM Sales | 2.2x | 2.7x | 3.3x | |
Upside (Analyst Target) | 31.2% | 37.5% | 38.9% | |
Fair Value Upside | Unlock | 21.8% | 5.4% | Unlock |